News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lammers Paul
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2022 |
4
| Lammers Paul (Director) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $0.48, valued at
$14.4k
|
|
| 12/04/2020 |
4
| Lammers Paul (Director) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $0.74, valued at
$22.2k
|
|
| 03/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2019 |
3
| Lammers Paul (Director) has filed a Form 3 on Salarius Pharmaceuticals, Inc. |
| 03/14/2016 |
4
| Lammers Paul (President & CEO) has filed a Form 4 on Mirna Therapeutics, Inc.|
Txns:
| Granted 165,000 options to buy
@ $4.36, valued at
$719.4k
|
|
| 09/30/2015 |
4
| Lammers Paul (President & CEO) has filed a Form 4 on Mirna Therapeutics, Inc.|
Txns:
| Granted 76,666 options to buy
@ $7, valued at
$536.7k
|
|
| 02/27/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/27/2009 |
3
| Lammers Paul (President) has filed a Form 3 on REPROS THERAPEUTICS INC. |
|
|